LABS vs. IHR, MXF, PHP, AGR, THRL, MLI, WHR, RDI, PCTN, and TPFG
Should you be buying Life Science REIT stock or one of its competitors? The main competitors of Life Science REIT include Impact Healthcare REIT (IHR), Medicx Fund (MXF), Primary Health Properties (PHP), Assura (AGR), Target Healthcare REIT (THRL), Industrials REIT (MLI), Warehouse REIT (WHR), Rdi Reit (RDI), Picton Property Income (PCTN), and The Property Franchise Group (TPFG). These companies are all part of the "real estate" sector.
Life Science REIT vs. Its Competitors
Life Science REIT (LON:LABS) and Impact Healthcare REIT (LON:IHR) are both small-cap real estate companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, earnings, risk, valuation and dividends.
Life Science REIT has a beta of 0.08, indicating that its share price is 92% less volatile than the S&P 500. Comparatively, Impact Healthcare REIT has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500.
Impact Healthcare REIT has higher revenue and earnings than Life Science REIT. Life Science REIT is trading at a lower price-to-earnings ratio than Impact Healthcare REIT, indicating that it is currently the more affordable of the two stocks.
In the previous week, Life Science REIT's average media sentiment score of 0.00 equaled Impact Healthcare REIT'saverage media sentiment score.
33.0% of Life Science REIT shares are owned by institutional investors. Comparatively, 59.5% of Impact Healthcare REIT shares are owned by institutional investors. 0.0% of Life Science REIT shares are owned by company insiders. Comparatively, 9.3% of Impact Healthcare REIT shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Impact Healthcare REIT has a net margin of 88.90% compared to Life Science REIT's net margin of -198.99%. Impact Healthcare REIT's return on equity of 9.90% beat Life Science REIT's return on equity.
Life Science REIT pays an annual dividend of GBX 0.01 per share and has a dividend yield of 0.0%. Impact Healthcare REIT pays an annual dividend of GBX 7 per share. Life Science REIT pays out -11.4% of its earnings in the form of a dividend. Impact Healthcare REIT pays out 6,363.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Life Science REIT is clearly the better dividend stock, given its higher yield and lower payout ratio.
Summary
Impact Healthcare REIT beats Life Science REIT on 10 of the 12 factors compared between the two stocks.
Get Life Science REIT News Delivered to You Automatically
Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding LABS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Life Science REIT Competitors List
Related Companies and Tools
This page (LON:LABS) was last updated on 10/6/2025 by MarketBeat.com Staff
